So what if we have CR to fund EMA trial. I only owned ANP for the past 18 months but reading through posts from very long term holders, ANP had come long way and had gone through many hardship on its own to get to where it is today. Derisked significantly with excellent result achieved from the previous trial and will be doing EMA trial next year.
We have well respected professionals that have involved in taking drugs from clinical trials through to commercialization.
Wouldnt it be better if we do CR and take the drug through to commercialization in EU? Only need $30 mil which I believe will have no issue in raising from even existing shareholders and mangement/board. Why giving away the pipe to some large pharma now given that we have derised so much.
I am greedy and want to keep all the $Billion in revenue haha. Revenue from EU in 18 months time more than enough for ANP to take the drug to the US and expanding the drug pipeline.
As long as CR is not at too much discounted I am happy and willing to sell my other stocks to participated.
Just my 2 cents opinion
Chart, page-4258
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.3¢ |
Change
0.004(5.80%) |
Mkt cap ! $65.81M | |||
| Open | High | Low | Value | Volume |
| 7.0¢ | 7.3¢ | 7.0¢ | $16.42K | 231.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 7.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.3¢ | 63510 | 1 |
View Market Depth
| Last trade - 16.10pm 01/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.2¢ |
Change
0.004 ( 2.86 %) |
||||
| Open | High | Low | Volume | ||
| 7.0¢ | 7.2¢ | 7.0¢ | 38700 | ||
| Last updated 13.48pm 01/05/2024 ? | |||||
| PER (ASX) Chart |